Literature DB >> 26728120

Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.

Stefano Molica1, Giovanna Digiesi2, Giovanni D'Arena3, Rosanna Mirabelli1, Anna Antenucci2, Laura Conti2, Massimo Gentile4, Pellegrino Musto3, Antonino Neri5, Fortunato Morabito4.   

Abstract

Entities:  

Keywords:  zzm321990CLLzzm321990; calreticulin; prognosis

Mesh：

Substances：

Year:  2016        PMID： 26728120     DOI： 10.1111/bjh.13907

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia.

Authors:  Elisa ten Hacken; Maria Gounari; Jaap Willem Back; Ekaterina Shimanovskaya; Lydia Scarfò; Ekaterina Kim; Jared Burks; Maurilio Ponzoni; Giuseppe Alvise Ramirez; William G Wierda; Zeev Estrov; Michael J Keating; Alessandra Ferrajoli; Kostas Stamatopoulos; Paolo Ghia; Jan A Burger
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

2.  Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57.

Authors:  Shing Tat Theodore Lam; Chinten James Lim
Journal:  Prog Mol Subcell Biol       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.